Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination antibiotic therapy in pediatrics.

E G Chadwick, R Yogev, S T Shulman

    The American Journal of Medicine
    |June 30, 1986
    PubMed
    Summary

    Beta-lactam and amikacin antibiotic combinations are effective for pediatric infections. Amikacin shows satisfactory results and low toxicity, supporting its continued use in pediatric care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.

    Clinical and experimental immunology·2017
    Same author

    Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.

    Clinical pharmacology and therapeutics·2014
    Same author

    A bioactive metallurgical grade porous silicon-polytetrafluoroethylene sheet for guided bone regeneration applications.

    Bio-medical materials and engineering·2014
    Same author

    CD84 is markedly up-regulated in Kawasaki disease arteriopathy.

    Clinical and experimental immunology·2014
    Same author

    Assessment of lopinavir pharmacokinetics with respect to developmental changes in infants and the impact on weight band-based dosing.

    Clinical pharmacology and therapeutics·2011
    Same author

    Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.

    Antimicrobial agents and chemotherapy·2009

    Area of Science:

    • Pediatric Infectious Diseases
    • Pharmacology
    • Antimicrobial Therapy

    Background:

    • Beta-lactam and aminoglycoside antibiotics are standard for pediatric infections.
    • Amikacin has been the exclusive aminoglycoside at this institution for five years.
    • These combinations are used empirically and definitively for various serious pediatric conditions.

    Purpose of the Study:

    • To evaluate the efficacy and safety of amikacin in combination antibiotic regimens for pediatric infections.
    • To assess the correlation between in vitro synergy and in vivo outcomes, particularly with amikacin and imipenem.

    Main Methods:

    • Retrospective review of amikacin usage in pediatric patients.
    • Analysis of clinical outcomes in patients receiving amikacin-based combination therapy.
    • Evaluation of in vitro synergy data and its correlation with in vivo efficacy.

    Main Results:

    • Amikacin in combination therapy yielded highly satisfactory clinical results across diverse pediatric infections.
    • Aminoglycoside toxicity, specifically with amikacin, was rarely observed.
    • Absence of in vitro synergy between amikacin and imipenem did not preclude improved survival in a relevant animal model.

    Conclusions:

    • Combination antibiotic regimens including amikacin remain crucial in pediatric infectious disease management.
    • Amikacin is a safe and effective aminoglycoside for empirical and definitive pediatric therapy.
    • In vitro synergy testing may underestimate the clinical benefit of certain antibiotic combinations, like amikacin and imipenem.

    Related Experiment Videos